ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | 0.0% | 47 | +14.6% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -83.3% | 41 | -84.5% | 0.00% | – |
| Q1 2017 | $6,000 | -25.0% | 265 | -34.4% | 0.00% | – |
| Q4 2016 | $8,000 | -63.6% | 404 | -61.5% | 0.00% | – |
| Q3 2016 | $22,000 | -43.6% | 1,049 | -31.3% | 0.00% | – |
| Q2 2016 | $39,000 | -15.2% | 1,527 | -11.8% | 0.00% | – |
| Q1 2016 | $46,000 | -51.1% | 1,731 | -21.5% | 0.00% | – |
| Q4 2015 | $94,000 | +44.6% | 2,204 | -10.3% | 0.00% | – |
| Q3 2015 | $65,000 | +828.6% | 2,456 | +1128.0% | 0.00% | – |
| Q3 2014 | $7,000 | +600.0% | 200 | +566.7% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |